Shanghai Haoyuan Chemexpress Co., Ltd. logo

Shanghai Haoyuan Chemexpress Co., Ltd. (688131)

Market Closed
12 Dec, 06:57
SSE SSE
¥
74. 44
+0.6
+0.81%
¥
10B Market Cap
- P/E Ratio
0.16% Div Yield
5,802,915 Volume
- Eps
¥ 73.84
Previous Close
Day Range
72.6 74.94
Year Range
31.8 90.58
Want to track 688131 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688131 closed Friday higher at ¥74.44, an increase of 0.81% from Thursday's close, completing a monthly decrease of -1.31% or ¥0.99. Over the past 12 months, 688131 stock gained 108.63%.
688131 pays dividends to its shareholders, with the most recent payment made on Oct 22, 2025. The next estimated payment will be in In 4 months on Apr 22, 2026 for a total of ¥0.08.
The last earnings report, released on Oct 29, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Shanghai Haoyuan Chemexpress Co., Ltd. has completed 2 stock splits, with the recent split occurring on Jun 27, 2024.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on SSE (CNY).

688131 Chart

Similar

Changchun BCHT Biotechnology Co., Ltd.
¥ 19.73
+0.1%
Zhejiang Taihua New Material Co., Ltd.
¥ 8.92
-0.78%
Ningbo Fujia Industrial Co., Ltd.
¥ 15.88
-0.13%
Xiamen King Long Motor Group Co., Ltd.
¥ 16.41
+0.12%
Sinomach Automobile Co. Ltd.
¥ 6.28
-0.16%

Shanghai Haoyuan Chemexpress Co., Ltd. (688131) FAQ

What is the stock price today?

The current price is ¥74.44.

On which exchange is it traded?

Shanghai Haoyuan Chemexpress Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688131.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.16%.

What is its market cap?

As of today, the market cap is 10B.

Has Shanghai Haoyuan Chemexpress Co., Ltd. ever had a stock split?

Shanghai Haoyuan Chemexpress Co., Ltd. had 2 splits and the recent split was on Jun 27, 2024.

Shanghai Haoyuan Chemexpress Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Baofu Zheng CEO
SSE Exchange
CNE1000051J4 ISIN
CN Country
3,370 Employees
22 Oct 2025 Last Dividend
27 Jun 2024 Last Split
- IPO Date

Overview

Shanghai Haoyuan Chemexpress Co., Ltd. is a prominent player in the pharmaceutical industry, dedicated to the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs. Established in 2006, the company has carved out a significant niche for itself in the competitive landscape of the pharmaceutical sector. Headquartered in Shanghai, China, it has earned a reputation for its excellence in producing high-quality Active Pharmaceutical Ingredients (APIs) and API intermediates. By focusing on innovation and precision, Shanghai Haoyuan Chemexpress has become an integral partner for pharmaceutical companies across the globe, enabling them to develop and produce effective, reliable pharmaceutical products.

Products and Services

  • APIs and API Intermediates: Shanghai Haoyuan Chemexpress Co., Ltd. specializes in the production of Active Pharmaceutical Ingredients (APIs) and API intermediates. These critical components are essential for the manufacturing of various pharmaceutical drugs, providing the fundamental therapeutic activity required for effective medication.
  • Vitamin D Series Compounds: The company is also known for its bespoke vitamin D series compounds. These compounds are crucial in the pharmaceutical industry for their myriad health benefits, particularly in the synthesis of medications aimed at treating bone disorders, calcium imbalances, and certain autoimmune diseases.
  • CRO Building Blocks: Offering a range of Contract Research Organization (CRO) building blocks, Shanghai Haoyuan Chemexpress caters to the foundational needs of pharmaceutical research and development. These building blocks are pivotal for research organizations in their quest to discover new drugs and therapeutic approaches.
  • CRO Life Bioscience Compounds: In addition to CRO building blocks, the company provides life bioscience compounds for contract research organizations. This service supports the drug discovery and development processes, helping CROs to accelerate their research and development timelines with high-quality, research-grade materials.

Contact Information

Address: No. 3 Building, No. 1999, Shanghai, China, 201203
Phone: 86 21 5899 8590